Growth Metrics

Intelligent Bio Solutions (INBS) Notes Payables (2022 - 2025)

Intelligent Bio Solutions' quarterly Notes Payables came in at $197146.0 in Q2 2025, down 61.74% year-on-year from $515282.0 in Q2 2024, and down 44.65% quarter-over-quarter from $356156.0 in Q1 2025.

Intelligent Bio Solutions has reported Notes Payables for 4 years, with the latest figure at $197146.0 in Q2 2025.

  • For the quarter ending Q2 2025, Notes Payables fell 61.74% year-over-year to $197146.0; the trailing twelve-month figure through Jun 2025 stood at $197146.0 (down 61.74% YoY), and the FY2025 full-year result was $197146.0, down 61.74% from the prior year.
  • Notes Payables for Q2 2025 stood at $197146.0, down from $356156.0 in the prior quarter.
  • The five-year high for Notes Payables was $523703.0 in Q4 2022, with the low at $197146.0 in Q2 2025.
  • Average Notes Payables over 4 years is $387913.5, with a median of $368513.0 recorded in 2024.
  • Year-over-year, Notes Payables soared 46.15% in 2024 and plunged 61.74% in 2025.
  • Tracing INBS's Notes Payables over 4 years: stood at $523703.0 in 2022, then slipped by 29.25% to $370535.0 in 2023, then rose by 9.45% to $405535.0 in 2024, then plunged by 51.39% to $197146.0 in 2025.
  • The last three Notes Payables figures came in at $197146.0 (Q2 2025), $356156.0 (Q1 2025), and $405535.0 (Q4 2024), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn
10 Intelligent Bio Solutions 13.61 Mn 12.40 Mn -

Historic Data

Download Data 🔒
DateValue
Jun 30, 2025 197,146.00
Mar 31, 2025 356,156.00
Dec 31, 2024 405,535.00
Sep 30, 2024 499,605.00
Jun 30, 2024 515,282.00
Mar 31, 2024 368,513.00
Dec 31, 2023 370,535.00
Sep 30, 2023 341,834.00
Jun 30, 2023 353,211.00
Mar 31, 2023 335,528.00
Dec 31, 2022 523,703.00